KATHARINE CUSHMA: Open Payments
NPI 1225588460 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 26 payments from 13 companies in 2025. Trend: 2023 $492 · 2024 $557 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| TerSera Therapeutics LLC | 6 | $180 |
| Boston Scientific Corporation | 2 | $149 |
| SPR Therapeutics, Inc | 3 | $75 |
| Abbott Laboratories | 3 | $66 |
| Averitas Pharma Inc. | 2 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $40 |
| AppliedVR Inc | 1 | $23 |
| Virtus Pharmaceuticals LLC | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
Products named: Prialt, General - Pain Management, SPRINT PNS System, QUTENZA, Belbuca, BOTOX, PENTA, Intracept.
Industry payments across PA — which companies pay providers there.
